Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenocarcinoma × S 1 (combination) × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 21 Colorectal Neoplasms 4 Biliary Tract Neoplasms 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Pancoast Syndrome 1 Neoplasms 1 Locally Advanced Gastric Adenocarcinoma 1 Klatskin Tumor 1 Hand-Foot Syndrome 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1 Advanced Gastric Cancer 1 Adenocarcinoma 1

Interventions

Oxaliplatin 8 Fluorouracil 6 Docetaxel 6 Paclitaxel 5 Leucovorin 5 Gemcitabine 5 Capecitabine 5 zolbetuximab 4 Cisplatin 4 Ramucirumab 3 Pemetrexed 3 Drug Therapy 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 regorafenib 2 pembrolizumab 2 Vinorelbine 2 Surgical Procedures, Operative 2 Nivolumab 2 Neoadjuvant Therapy 2 Cyclophosphamide 2 Chemoradiotherapy 2 Bevacizumab 2 Afatinib 2 vandetanib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pralsetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03013010 2025-12-08

PREACT

Shanghai Cancer Hospital, China

Phase 3 Completed

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡